These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17266986)

  • 21. Structure-function relationship of serine protease-protein inhibitor interaction.
    Otlewski J; Jaskólski M; Buczek O; Cierpicki T; Czapińska H; Krowarsch D; Smalas AO; Stachowiak D; Szpineta A; Dadlez M
    Acta Biochim Pol; 2001; 48(2):419-28. PubMed ID: 11732612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and comparative 3D modeling of CmPI-II, a novel 'non-classical' Kazal-type inhibitor from the marine snail Cenchritis muricatus (Mollusca).
    González Y; Pons T; Gil J; Besada V; Alonso-del-Rivero M; Tanaka AS; Araujo MS; Chávez MA
    Biol Chem; 2007 Nov; 388(11):1183-94. PubMed ID: 17976011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure of the complex of Streptomyces griseus proteinase B and polypeptide chymotrypsin inhibitor-1 from Russet Burbank potato tubers at 2.1 A resolution.
    Greenblatt HM; Ryan CA; James MN
    J Mol Biol; 1989 Jan; 205(1):201-28. PubMed ID: 2494344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal and molecular structures of the complex of alpha-chymotrypsin with its inhibitor turkey ovomucoid third domain at 1.8 A resolution.
    Fujinaga M; Sielecki AR; Read RJ; Ardelt W; Laskowski M; James MN
    J Mol Biol; 1987 May; 195(2):397-418. PubMed ID: 3477645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMR determination of pKa values for Asp, Glu, His, and Lys mutants at each variable contiguous enzyme-inhibitor contact position of the turkey ovomucoid third domain.
    Song J; Laskowski M; Qasim MA; Markley JL
    Biochemistry; 2003 Mar; 42(10):2847-56. PubMed ID: 12627950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and energetics of protein-protein interactions: the role of conformational heterogeneity in OMTKY3 binding to serine proteases.
    Horn JR; Ramaswamy S; Murphy KP
    J Mol Biol; 2003 Aug; 331(2):497-508. PubMed ID: 12888355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of Kazal-type inhibitor domains with serine proteinases: biochemical and structural studies.
    Schlott B; Wöhnert J; Icke C; Hartmann M; Ramachandran R; Gührs KH; Glusa E; Flemming J; Görlach M; Grosse F; Ohlenschläger O
    J Mol Biol; 2002 Apr; 318(2):533-46. PubMed ID: 12051857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thermodynamics and kinetics of the hydrolysis and resynthesis of the reactive site peptide bond in turkey ovomucoid third domain by aspergillopeptidase B.
    Ardelt W; Laskowski M
    Acta Biochim Pol; 1983; 30(2):115-26. PubMed ID: 6346765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissecting the energetics of a protein-protein interaction: the binding of ovomucoid third domain to elastase.
    Baker BM; Murphy KP
    J Mol Biol; 1997 May; 268(2):557-69. PubMed ID: 9159490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compromise and accommodation in ecotin, a dimeric macromolecular inhibitor of serine proteases.
    Gillmor SA; Takeuchi T; Yang SQ; Craik CS; Fletterick RJ
    J Mol Biol; 2000 Jun; 299(4):993-1003. PubMed ID: 10843853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Progresses in the structure and function of Kazal-type proteinase inhibitors].
    Zheng QL; Sheng Q; Zhang YZ
    Sheng Wu Gong Cheng Xue Bao; 2006 Sep; 22(5):695-700. PubMed ID: 17037188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interscaffolding additivity: binding of P1 variants of bovine pancreatic trypsin inhibitor to four serine proteases.
    Krowarsch D; Dadlez M; Buczek O; Krokoszynska I; Smalas AO; Otlewski J
    J Mol Biol; 1999 May; 289(1):175-86. PubMed ID: 10339415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMR chemical shift mapping of the binding site of a protein proteinase inhibitor: changes in the (1)H, (13)C and (15)N NMR chemical shifts of turkey ovomucoid third domain upon binding to bovine chymotrypsin A(alpha).
    Song J; Markley JL
    J Mol Recognit; 2001; 14(3):166-71. PubMed ID: 11391787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory specificity change of the ovomucoid third domain of the silver pheasant upon introduction of an engineered Cys14-Cys39 bond.
    Hemmi H; Kumazaki T; Yamazaki T; Kojima S; Yoshida T; Kyogoku Y; Katsu M; Shinohara F; Yokosawa H; Miura K; Kobayashi Y
    Biochemistry; 2003 Mar; 42(9):2524-34. PubMed ID: 12614146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testing of the additivity-based protein sequence to reactivity algorithm.
    Qasim MA; Lu W; Lu SM; Ranjbar M; Yi Z; Chiang YW; Ryan K; Anderson S; Zhang W; Qasim S; Laskowski M
    Biochemistry; 2003 Jun; 42(21):6460-6. PubMed ID: 12767228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of the subtilisin Carlsberg-OMTKY3 complex reveals two different ovomucoid conformations.
    Maynes JT; Cherney MM; Qasim MA; Laskowski M; James MN
    Acta Crystallogr D Biol Crystallogr; 2005 May; 61(Pt 5):580-8. PubMed ID: 15858268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional evolution within a protein superfamily.
    Yi Z; Vitek O; Qasim MA; Lu SM; Lu W; Ranjbar M; Li J; Laskowski MC; Bailey-Kellogg C; Laskowski M
    Proteins; 2006 May; 63(3):697-708. PubMed ID: 16463276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended intermolecular interactions in a serine protease-canonical inhibitor complex account for strong and highly specific inhibition.
    Fodor K; Harmat V; Hetényi C; Kardos J; Antal J; Perczel A; Patthy A; Katona G; Gráf L
    J Mol Biol; 2005 Jul; 350(1):156-69. PubMed ID: 15922357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of eglin-c binding to thermitase: three-dimensional structure comparison of native thermitase and thermitase eglin-c complexes.
    Gros P; Teplyakov AV; Hol WG
    Proteins; 1992 Jan; 12(1):63-74. PubMed ID: 1553381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting proteinase specificities from free energy calculations.
    Mekonnen SM; Olufsen M; Smalås AO; Brandsdal BO
    J Mol Graph Model; 2006 Oct; 25(2):176-85. PubMed ID: 16386933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.